Skip to content

13F-HR/A filed by PARAMETRIC PORTFOLIO ASSOCIATES LLC

PARAMETRIC PORTFOLIO ASSOCIATES LLC filed this 13F-HR/A for the quarter ended 2021-06-30, filed 2021-09-03, with 3,558 holding rows worth $178,439,109,000.

Accession
0000950123-21-012109
Filed
2021-09-03
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2021

A holdings report, amendment of type restatement, 3,592 entries on the cover page, a total value of $178,439,109,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $178,439,109,000 with VALUE read as thousands by filing date, 13F file number 028-04558. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GARRETT MOTION INC366505105COM10,511$84,000thousands by filing date
META MATERIALS INC59134N104COM10,941$82,000thousands by filing date
PAYSIGN INC70451A104COM25,074$80,000thousands by filing date
INFORMATION SVCS GROUP INC45675Y104COM13,494$79,000thousands by filing date
SANDRIDGE ENERGY INC80007P869COM NEW12,603$79,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM11,579$79,000thousands by filing date
SEELOS THERAPEUTICS INC81577F109COM29,449$78,000thousands by filing date
VIRNETX HLDG CORP92823T108COM17,742$76,000thousands by filing date
UR-ENERGY INC91688R108COM53,263$75,000thousands by filing date
SOCIETAL CDMO INC75629F109COM32,318$75,000thousands by filing date
IVERIC BIO INC46583P102COM11,507$73,000thousands by filing date
TONIX PHARMACEUTICALS HOLDIN890260706COM65,249$72,000thousands by filing date
PC TEL INC69325Q105COM11,004$72,000thousands by filing date
SIEBERT FINL CORP826176109COM14,762$71,000thousands by filing date
DASEKE INC23753F107COM10,939$71,000thousands by filing date
GOLD RESOURCE CORP38068T105COMMON STOCK27,069$70,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock34,001$69,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM19,259$67,000thousands by filing date
LINEAGE CELL THERAPEUTICS IN53566P109COMMON STOCK23,229$66,000thousands by filing date
RESONANT INC76118L102COM19,675$63,000thousands by filing date
VOYAGER THERAPEUTICS INC92915B106COMMON STOCK15,000$62,000thousands by filing date
Fluent Co34380C102COM21,300$62,000thousands by filing date
BIORA THERAPEUTICS INC74319F107COM17,347$62,000thousands by filing date
SMITH MICRO SOFTWARE INC832154207COMMON11,849$62,000thousands by filing date
ORION GROUP HOLDINGS INC68628V308COMMON STOCK10,611$61,000thousands by filing date
FIVE STAR SENIOR LIVING INC33832D205COM NEW10,421$60,000thousands by filing date
CITIUS PHARMACEUTICALS INC17322U207COM17,385$60,000thousands by filing date
AQUABOUNTY TECHNOLOGIES INC03842K200COM NEW11,068$59,000thousands by filing date
IRSA INVERSIONES Y REP S A SPON GDS ECH 10450047204ADR15,133$56,000thousands by filing date
QUAD / GRAPHICS INC747301109COM CL A13,142$55,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637113SHS41,079$55,000thousands by filing date
NEUROBO PHARMACEUTICALS INC64132R107COM16,530$55,000thousands by filing date
NYMOX PHARMACEUTICAL CORP ORD SHS CorpP73398102Common Stock33,665$53,000thousands by filing date
TEEKAY CORPORATIONY8564W103COM13,324$50,000thousands by filing date
HALL OF FAME RESORT & ENTMT40619L102COM12,688$50,000thousands by filing date
CYCLERION THERAPEUTICS INC23255M105COM12,596$49,000thousands by filing date
HC2 HLDGS INC404139107COM12,389$49,000thousands by filing date
DHI GROUP INC23331S100COM14,340$48,000thousands by filing date
22ND CENTY GROUP INC90137F103COM10,182$47,000thousands by filing date
RESEARCH FRONTIERS INC760911107COM18,654$44,000thousands by filing date
Checkpoint Therapeutics Inc Com162828107COM14,697$43,000thousands by filing date
AKERNA CORP00973W102COM10,101$41,000thousands by filing date
ACER THERAPEUTICS INC00444P108CMN14,134$40,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM13,298$39,000thousands by filing date
CUMBERLAND PHARMACEUTICALS I230770109COM13,296$38,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM10,254$38,000thousands by filing date
VISTAGEN THERAPEUTICS INC92840H202COM12,064$38,000thousands by filing date
Ampio Pharmaceuticals03209T109COM22,216$37,000thousands by filing date
GENPREX INC372446104COM10,833$36,000thousands by filing date
MUSTANG BIO INC62818Q104COM10,850$36,000thousands by filing date
GENIUS BRANDS INTERNATIONAL INC37229T301COMMON STOCK18,779$35,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM10,234$31,000thousands by filing date
AGROFRESH SOLUTIONS INC00856G109COM13,416$28,000thousands by filing date
VTV THERAPEUTICS INC CL A918385105Stock12,444$28,000thousands by filing date
MARRONE BIO INNOVATIONS INC57165B106COM15,810$26,000thousands by filing date
AVENUE THERAPEUTICS INC05360L205COM10,554$26,000thousands by filing date
AGILE THERAPEUTICS INC00847L100COM12,959$17,000thousands by filing date
GABELLI EQUITY TR INC362397218RIGHT 07/14/202120,240$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-21-010884 superseded2021-08-13acceptance time not in the bulk data set
13F-HR/A 0000950123-21-012109this filing2021-09-03acceptance time not in the bulk data set